HealthcareServices

GI Stool Testing Market Outlook 2026–2035: Growth Drivers and Industry Forecast

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the gi stool testing market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the GI Stool Testing Market expected to reach by 2030?

The gi stool testing market size has demonstrated robust expansion in recent years. It is projected to expand from $1.41 billion in 2025 to $1.51 billion in 2026, registering a compound annual growth rate (CAGR) of 7.4%. Historically, this expansion can be attributed to factors such as an increase in gastrointestinal disorders, developments in diagnostic laboratories, the introduction of early microbiology testing, an uptick in colorectal cancer screening, and greater healthcare awareness.

The gi stool testing market is projected for robust expansion over the coming years, with its valuation expected to reach $1.99 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.1%. This anticipated growth is driven by factors such as the increasing availability of personalized gut health testing, the rise of home diagnostics, the incorporation of AI-based analysis, wider adoption of preventive healthcare practices, and greater public understanding of digestive health. Key developments anticipated during this period involve a rising preference for non-invasive diagnostic tools, increasing acceptance of microbiome-focused testing, enhanced application of molecular diagnostic techniques, the proliferation of home-based stool testing kits, and better initial identification of GI disorders.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23410&type=smp

What Drivers Are Driving Adoption Within The GI Stool Testing Market?

The anticipated expansion of the GI stool testing market is linked to the growing incidence of gastrointestinal disorders. These disorders encompass conditions impacting the digestive system, such as the stomach, intestines, and associated organs, manifesting symptoms like nausea, diarrhea, constipation, and abdominal pain. A primary factor behind the increase in these conditions is inadequate dietary practices, as greater consumption of processed foods, high sugar intake, and diets low in fiber disrupt gut microbiota, compromise digestive well-being, and contribute to ailments like acid reflux, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD). For an accurate diagnosis and targeted treatment of gastrointestinal disorders, GI stool testing is crucial. It aids in identifying pathogens (bacteria, viruses, parasites), indicators of gut inflammation, and digestive enzyme insufficiencies. An example of this trend is the report issued in September 2024 by the Centers for Disease Control and Prevention, a US-based government agency, stating that between 2024 and 2025, NoroSTAT-participating states reported 1,676 norovirus outbreaks, which was a substantial increase from the 729 outbreaks recorded during the same period last season. Consequently, the rising occurrence of gastrointestinal disorders fuels the growth of the GI stool testing market.

How Is The GI Stool Testing Market Organized Into Various Segments?

The gi stool testing market covered in this report is segmented –

1) By Type: Immunoassay Test, Molecular Diagnostic Test, Chromatography-Based Test, Microbiological Culture Test, Enzyme-Linked Immunosorbent Assay (ELISA)

2) By Sample Type: Fecal Samples, Serum Samples

3) By Equipment: Automated Analyzers, Benchtop Instruments, Portable Devices

4) By Application: Diagnosis Of Gastrointestinal Disorders, Screening For Colorectal Cancer, Monitoring Of Inflammatory Bowel Disease (IBD), Detection Of Gastrointestinal Infections, Evaluation Of Digestive Health

5) By End User: Hospital, Diagnostic Centre And Laboratory, Academic Institution, Research Centre Organization, Homecare, Other End Users

Subsegments:

1) By Immunoassay Test: Rapid Immunoassay, Lateral Flow Assay, Fluorescent Immunoassay

2) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Test (NAAT), Next-Generation Sequencing (NGS)

3) By Chromatography-Based Test: Gas Chromatography (GC), Liquid Chromatography (LC), Thin-Layer Chromatography (TLC)

4) By Microbiological Culture Test: Aerobic Culture, Anaerobic Culture, Selective Media Culture

5) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA, Indirect ELISA, Sandwich ELISA, Competitive ELISA

What Long-Term Trends Are Expected To Shape The Future Of The GI Stool Testing Market?

Major entities operating in the GI stool testing market are prioritizing sophisticated testing methodologies, such as extensive diagnostic evaluations, to enhance precision, speed, and timely disease identification. An extensive diagnostic evaluation serves as an advanced medical instrument that simultaneously assesses various health indicators, thereby providing a comprehensive understanding of a condition. For instance, in November 2024, EmeritusDX, a US-based diagnostics company, introduced GI Detect, a thorough diagnostic examination designed to aid healthcare professionals in detecting gastrointestinal disorders. This innovative test employs a single stool swab to identify 26 bacteria, viruses, and parasites linked to disruptions in the digestive system. With a 24-hour turnaround time, GI Detect supports rapid and well-informed clinical decision-making. Beyond its capacity for broad pathogen detection, the test also screens for Helicobacter pylori and its virulence factors VacA, cagA, and babA, along with typical gastrointestinal parasites such as Cryptosporidium, Entamoeba histolytica, and Giardia lamblia. This all-encompassing method guarantees accurate and prompt diagnosis of gastrointestinal infections.

Who Are The Top-Performing Companies In The GI Stool Testing Market In Recent Years?

Major companies operating in the gi stool testing market are Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Hologic Inc., Biomerieux SA, Bio-Rad Laboratories Inc., Meridian BioScience Inc., Diasorin SPA, ELITechGroup, Genova Diagnostics Inc., US BioTek Laboratories LLC, Doctor’s Data Inc., Diagnostic Solutions Laboratory LLC, Functional Medical Institute Pvt. Ltd., Walk-In Lab LLC, ScheBo Biotech AG, Qiagen NV, Roche Diagnostics, Siemens Healthineers, QuidelOrtho Corporation, Biohit Oyj, Exact Sciences Corporation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/gi-stool-testing-global-market-report

How Does The GI Stool Testing Market Perform Across Major Global Regions?

North America was the largest region in the GI stool testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gi stool testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized GI Stool Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=23410&type=smp

Browse Through More Reports Similar to the Global GI Stool Testing Market 2026, By The Business Research Company

Bowel Management Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/bowel-management-systems-global-market-report

Monkey Pox Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/monkey-pox-testing-global-market-report

Enteric Disease Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795